Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Adriana Karaboutis joins Biogen Idec from Dell

She is appointed executive vice president, technology and business solutions

- PMLiVE

Major depression in UK cancer patients going untreated

Only 17% of patients reacted to usual NHS therapy according to new research

- PMLiVE

UK payer perspectives: the market access value paradox

'UK payer perspectives: the market access value paradox' will feature Ryan Wooller, director of market access and service innovation at Quintiles and Dr Junaid Bajwa, a GP and board member...

- PMLiVE

England’s Cancer Drugs Fund receives new funding boost

Gains an extra £160m to pay for drugs not recommended by NICE

- PMLiVE

BMS can ride on Sovaldi’s success as Daklinza cleared in EU

Hepatitis C drug approved in combination with Gilead’s huge-selling treatment

- PMLiVE

Amgen gets priority review for chronic heart failure hope

Raises expectations for early entry onto US market for ivabradine

- PMLiVE

NICE wants more data on Boehringer’s Jardiance

Pharma company needs to demonstrate cost-effectiveness of its diabetes drug

- PMLiVE

Pharma takes the ALS Ice Bucket Challenge

GSK, Evotec and Biogen Idec participate in the social media sensation

- PMLiVE

H&T Asia promotes Monika James

She moves up to senior account director

- PMLiVE

Citation needed: pharma needs to make the most of Wikipedia

The online encyclopedia is an increasingly important source of knowledge for patients and information must be kept accurate and up to date

- PMLiVE

WPP buys two more firms

Strengthens Millward Brown and GroupM with purchase of InsightExpress and Keyade

- PMLiVE

Biogen Idec names ALS unit head

Donald Johns joins from Novartis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links